Range
3.86 - 4.03
Vol / Avg.
37.1K/65.6K
Div / Yield
-
52 Wk
3.17 - 8.8
Mkt Cap
40.3M
Payout Ratio
-
Open
4
P/E
-
EPS
-0.09
Shares
10.1M
Outstanding
10.1M
Total Float
-
Benzinga - 6 days ago
Benzinga - Jun 4, 2021, 9:22AM
Benzinga - May 26, 2021, 8:09AM
Benzinga - May 12, 2021, 4:27PM
Benzinga - Apr 15, 2021, 8:04AM
Benzinga - Apr 6, 2021, 8:22AM
Benzinga - Mar 25, 2021, 4:18PM
Benzinga - Mar 10, 2021, 9:42AM
Benzinga - Mar 10, 2021, 9:34AM
Benzinga - Mar 8, 2021, 10:08AM
Benzinga - Feb 10, 2021, 12:12PM
Benzinga - Feb 10, 2021, 8:50AM
Benzinga - Feb 10, 2021, 8:37AM
Benzinga - Feb 10, 2021, 8:08AM
Benzinga - Feb 10, 2021, 8:04AM
Benzinga - Feb 10, 2021, 7:58AM
load more
Sector: Health Care.Industry: Biotechnology
Panbela Therapeutics Inc is a clinical-stage drug development company. It is engaged in the commercial development of a proprietary polyamine analogue for pancreatic cancer and for the second indication in chronic pancreatitis. The firm has developed polyamine analogue compound referred as SBP-101 for the exocrine pancreas, with therapeutic potential for both pancreatic cancer and pancreatitis indications.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.110-0.230 -0.1200
REV0
Q4 2020Est.ActualSurprise
EPS-0.090
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
PBLAPanbela Therapeutics-3.26%40.3M

Panbela Therapeutics Frequently Asked Questions

Q

How do I buy Panbela Therapeutics (PBLA) stock?

A

You can purchase shares of Panbela Therapeutics (NASDAQ: PBLA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Panbela Therapeutics's (PBLA) competitors?

A

Other companies in Panbela Therapeutics’s space includes: Immuron (NASDAQ:IMRN), Synaptogenix (NASDAQ:SNPX), Histogen (NASDAQ:HSTO), Midatech Pharma (NASDAQ:MTP) and Soligenix (NASDAQ:SNGX).

Q

What is the target price for Panbela Therapeutics (PBLA) stock?

A

The latest price target for Panbela Therapeutics (NASDAQ: PBLA) was reported by Maxim Group on March 10, 2021. The analyst firm set a price target for 8.00 expecting PBLA to rise to within 12 months (a possible 100.50% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Panbela Therapeutics (PBLA)?

A

The stock price for Panbela Therapeutics (NASDAQ: PBLA) is $3.99 last updated Today at 8:00:02 PM.

Q

Does Panbela Therapeutics (PBLA) pay a dividend?

A

There are no upcoming dividends for Panbela Therapeutics.

Q

When is Panbela Therapeutics (NASDAQ:PBLA) reporting earnings?

A
Panbela Therapeutics’s Q2 earnings are confirmed for after-market on August 8, 2021.
Q

Is Panbela Therapeutics (PBLA) going to split?

A

There is no upcoming split for Panbela Therapeutics.

Q

What sector and industry does Panbela Therapeutics (PBLA) operate in?

A

Panbela Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.